GSTZ 1‐1 Deficiency Activates NRF 2/ IGF 1R Axis in HCC via Accumulation of Oncometabolite Succinylacetone
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
GSTZ
1‐1 Deficiency Activates
NRF
2/
IGF
1R Axis in
HCC
via Accumulation of Oncometabolite Succinylacetone
Authors
Keywords
-
Journal
EMBO JOURNAL
Volume -, Issue -, Pages -
Publisher
EMBO
Online
2019-07-10
DOI
10.15252/embj.2019101964
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NRF2 and the Hallmarks of Cancer
- (2018) Montserrat Rojo de la Vega et al. CANCER CELL
- Glutathione transferases: substrates, inihibitors and pro-drugs in cancer and neurodegenerative diseases
- (2018) Nerino Allocati et al. Oncogenesis
- Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1
- (2018) Evanna L. Mills et al. NATURE
- GSTZ1 expression and chloride concentrations modulate sensitivity of cancer cells to dichloroacetate
- (2016) Stephan C. Jahn et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- An overview of chemical inhibitors of the Nrf2-ARE signaling pathway and their potential applications in cancer therapy
- (2016) Jiayu Zhu et al. FREE RADICAL BIOLOGY AND MEDICINE
- Hypersuccinylacetonaemia and normal liver function in maleylacetoacetate isomerase deficiency
- (2016) Hao Yang et al. JOURNAL OF MEDICAL GENETICS
- Sustained NRF2 activation in hereditary leiomyomatosis and renal cell cancer (HLRCC) and in hereditary tyrosinemia type 1 (HT1)
- (2015) Ivraj Singh Sandhu et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Molecular basis of the Keap1–Nrf2 system
- (2015) Takafumi Suzuki et al. FREE RADICAL BIOLOGY AND MEDICINE
- Keap1–Nrf2 signalling in pancreatic cancer
- (2015) Alastair J. Hayes et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Understanding the Key to Targeting the IGF Axis in Cancer: A Biomarker Assessment
- (2015) Kunal Amratlal Lodhia et al. Frontiers in Oncology
- Nrf2 ameliorates diabetic nephropathy progression by transcriptional repression of TGFβ1 through interactions with c-Jun and SP1
- (2014) Pan Gao et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Transcriptional and epigenetic control of IGF1R gene expression: Implications in metabolism and cancer
- (2014) Haim Werner et al. GROWTH HORMONE & IGF RESEARCH
- Succinylacetone as primary marker to detect tyrosinemia type I in newborns and its measurement by newborn screening programs
- (2014) Víctor R. De Jesús et al. MOLECULAR GENETICS AND METABOLISM
- Serine and glycine metabolism in cancer
- (2014) Ivano Amelio et al. TRENDS IN BIOCHEMICAL SCIENCES
- The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
- (2014) John D. Hayes et al. TRENDS IN BIOCHEMICAL SCIENCES
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
- (2012) Patrick S. Ward et al. CANCER CELL
- Renal Cyst Formation in Fh1-Deficient Mice Is Independent of the Hif/Phd Pathway: Roles for Fumarate in KEAP1 Succination and Nrf2 Signaling
- (2011) Julie Adam et al. CANCER CELL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Targeting cancer metabolism: a therapeutic window opens
- (2011) Matthew G. Vander Heiden NATURE REVIEWS DRUG DISCOVERY
- Upregulation of the Insulin Receptor and Type I Insulin-Like Growth Factor Receptor Are Early Events in Hepatocarcinogenesis
- (2011) Eiman Aleem et al. TOXICOLOGIC PATHOLOGY
- Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer
- (2008) E D Michelakis et al. BRITISH JOURNAL OF CANCER
- Activation of nuclear factor E2-related factor 2 in hereditary tyrosinemia type 1 and its role in survival and tumor development
- (2008) Silke Marhenke et al. HEPATOLOGY
- Dual roles of Nrf2 in cancer
- (2008) A LAU et al. PHARMACOLOGICAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More